Equities

Vycor Medical Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
VYCO:QBB

Vycor Medical Inc

Actions
  • Price (USD)0.11
  • Today's Change0.00 / 0.00%
  • Shares traded1.00k
  • 1 Year change--
  • Beta-0.5827
Data delayed at least 15 minutes, as of Feb 06 2026 18:49 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company designs, develops and markets neurological medical devices and therapies. The Company operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage, such as that caused by a stroke. Vycor Medical’s ViewSite Brain Access System (VBAS) is a next-generation retraction and access system. VBAS is a minimally invasive neurosurgical device designed to improve access to brain lesions while reducing tissue damage and enhancing patient outcomes. The VBAS system is used in over 300 hospitals in the United States and in numerous countries internationally. NovaVision products include Visual Restoration Therapy (VRT) and NeuroEyeCoach.

  • Revenue in USD (TTM)1.90m
  • Net income in USD-338.88k
  • Incorporated2007
  • Employees7.00
  • Location
    Vycor Medical Inc951 Broken Sound Parkway, Suite 320BOCA RATON 33487United StatesUSA
  • Phone+1 (561) 558-2020
  • Fax+1 (631) 794-2444
  • Websitehttps://www.vycormedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Catheter Precision Inc730.00k-22.19m2.39m22.00--0.3473--3.27-37.38-37.380.93714.120.0281.646.3533,181.82-66.93-128.03-78.29-160.1292.60-242.70-2,393.84-15,268.880.4569-66.840.0449---4.98-19.8969.45---24.21--
Profusa Inc0.00-39.09m2.48m0.00---------278.73-278.730.00-61.050.00-------599.88-----------------14.56---------849.77------
INVO Fertility Inc6.94m-27.13m2.53m28.00------0.3644-602.89-644.6750.028.630.387419.5026.14247,996.40-149.96-63.14-299.48-98.9639.1760.46-387.11-276.300.1022-10.360.2530--116.2534.57-16.33--9.88--
Aethlon Medical Inc0.00-11.26m2.58m9.00--0.2597-----56.69-56.690.007.550.00----0.00-139.25-86.44-181.09-98.06-------3,662.04----0.00-------9.67------
Work Medical Technology Group Ltd9.85m-1.07m2.62m238.00--0.0071--0.2662-241.35-241.353,396.11214.42------41,381.18--1.52--4.5623.8122.30-12.192.521.50-7.760.23190.00-14.41-28.4569.28---39.54--
Fuse Medical Inc18.40m3.63m2.96m31.001.11--0.80140.16060.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
ENvue Medical Inc2.69m-5.21m3.08m15.00--0.0674--1.15-83.93-83.937.4642.000.09090.83646.45179,000.00-25.01-97.63-32.90-149.1830.0253.04-275.12-397.830.6675--0.0669--12.0537.000.1617------
Encision Inc6.30m-380.94k3.19m22.00--1.71--0.5064-0.0284-0.02840.50570.11051.662.277.98286,353.60-10.05-3.17-14.19-4.4052.6451.47-6.05-2.010.9127-5.690.1094---0.464-3.0968.17--8.09--
Vycor Medical Inc1.90m-338.88k3.67m7.00------1.93-0.0103-0.01030.0548-0.12061.891.576.73271,678.60-1.44-36.90----85.3589.43-0.7625-26.120.10280.8609----8.812.67-11.32---40.90--
Nuwellis Inc8.17m-16.56m3.69m38.00--0.6881--0.452-107.66-107.6626.642.871.111.656.71214,947.40-225.22-87.78-390.32-108.5359.0757.73-202.83-195.831.42-1.050.00---1.409.6653.05---34.30--
Avalon Globocare Corp1.40m-18.76m3.74m5.00------2.68-9.75-9.750.6074-1.100.0974--16.92279,216.00-131.94-76.04-1,379.37-114.3725.7023.19-1,355.20-888.890.1477-4.072.69--6.19-2.9252.69------
Axim Biotechnologies Inc92.90k-4.14m3.97m6.00------42.78-0.0163-0.01630.0003-0.03240.0233----15,483.33-103.73-154.34---390.7316.94---4,451.97-36,362.71---3.14----345.05-27.38-29.10------
Reflect Scientific Inc1.72m-29.42k4.04m7.00--1.9421.592.34-0.0004-0.00040.02010.02430.68260.84298.78245,945.70-1.1711.10-1.3213.2158.4762.48-1.7110.009.46--0.00---47.09-6.99-613.46------
Autonomix Medical Inc0.00-16.69m4.37m8.00--0.3684-----5.08-5.080.001.040.00----0.00-250.94---316.15--------------0.00------26.03------
bioAffinity Technologies Inc6.78m-14.74m4.68m57.00--0.4050--0.6904-20.74-20.749.342.570.7489161.377.97118,890.20-162.88---222.52--27.86---217.50--3.64-2.690.0332--269.68---13.89------
Data as of Feb 06 2026. Currency figures normalised to Vycor Medical Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.